Clinical Operational Tolerance After Solid Organ Transplantation

Transplantation Proceedings

Volumn 41, Issue 4, 2009, Pages 1278-1282

  Di Cocco, P ^a   Bonanni, L ^a   D'Angelo, M ^a   Clemente, K ^a   Greco, S ^a   Rizza, V ^a   Mazzotta, C ^a   Scelzo, C ^b   Famulari, A ^a   Pisani, F ^a   Orlando, G ^c,d  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASE; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BONE MARROW TRANSPLANTATION; GRAFT FAILURE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; ORGAN TRANSPLANTATION; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; RISK REDUCTION; TRANSPLANTATION TOLERANCE; TREATMENT INDICATION; IMMUNOLOGICAL TOLERANCE;

HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION;

EID: 65549145397     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.003     Document Type: Article

References (41)

1. Orlando G, Soker S, Wood KJ: Clinical operational tolerance after liver transplantation. J Hepatol, in press
2. Tisone G., Orlando G., and Angelico M. Operational tolerance in clinical liver transplantation: emerging developments. Transpl Imm 17 (2007) 108
3. Tisone G., Orlando G., Cardillo A., et al. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol 44 (2006) 702
4. Orlando G., Manzia T., Baiocchi L., et al. The Tor Vergat Weaning Off Immunosuppression Trial in HCV liver transplant patients. The updated follow up at 78 months. Transpl Immunol 20 (2008) 43
5. Merrill J.P., Murray J.E., and Harrison J.H. Successful homotransplantation of the human kidney between identical twins. JAMA 160 (1956) 277
6. Starzl T.E., Murase N., Demetris A.J., et al. Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation 77 (2004) 926
7. Weil III R., Starzl T.E., Porter K.A., et al. Renal isotransplantation without immunosuppression. Ann Surg 192 (1980) 108
8. Butcher J.A., Hariharan S., Adams M.B., et al. Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression. Clin Transpl 13 (1999) 330
9. Sayegh M.H., Fine N.A., Smith J.L., et al. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 114 (1991) 954
10. Sellers M.T., Deierhoi M.H., Curtis J.J., et al. Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up. Transplantation 71 (2001) 1681
11. Jacobsen N., Taaning E., Ladefoged J., et al. Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet 343 (1994) 800
12. Helg C., Chapuis B., Bolle J.F., et al. Renal transplantation without immunosuppression in a host with tolerance induced byallogeneic bone marrow transplantation. Transplantation 58 (1994) 1420
13. Sorof J.M., Koerper M.A., Portale A.A., et al. Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation. Transplantation 59 (1995) 1633
14. Buhler L.H., Spitzer T.R., and Sykes M. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 74 (2002) 1405
15. Fudaba Y., Spitzer T.R., Shaffer J., et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transpl 6 (2006) 2121
16. Spitzer T.R., Delmonico F., Tolkoff-Rubin N., et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 68 (1999) 480
17. Kawai T., Cosimi A.B., Spitzer T.R., et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358 (2008) 353
18. Millan M.T., Shizuru J.A., Hoffmann P., et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 73 (2002) 1386
19. Scandling J.D., Busque S., Dejbakhsh-Jones S., et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 358 (2008) 362
20. Strober S., Benike C., Krishnaswamy S., et al. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Transplantation 69 (2000) 1549
21. Strober S., Dhillon M., Schubert M., et al. Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med 321 (1989) 28
22. Burlingham W.J., Grailer A.P., Fechner Jr. J.H., et al. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 59 (1995) 1147
23. Christensen L.L., Grunnet N., Rüdiger N., et al. Indications of immunological tolerance in kidney transplantation. Tissue Antigen 51 (1998) 637
24. Zoller K.M., Cho S.I., Cohen J.J., et al. Cessation of immunosuppressive therapy after successful transplantation: a national survey. Kidney Int 18 (1980) 110
25. Zonnebelt S.M., and Belzer F.O. Kidney transplantation in monozygotic twins discordant for lupus. JAMA 245 (1981) 68
26. Kuss R., Legrain M., Mathe G., et al. Homologous human kidney transplantation. Experience with six patients. Postgrad Med J 38 (1962) 528
27. Hamburger J., Vaysse J., Crosnier J., et al. Renal homotransplantation in man after radiation of the recipient. Am J Medic 32 (1962) 854
28. Trivedi H.L., Vanikar A.V., Vakil J.M., et al. A strategy to achieve donor-specific hyporesponsiveness in cadaver renal allograft recipients by donor haematopoietic stem cell transplantation into the thymus and periphery. Nephrol Dial Transplant 19 (2004) 2374
29. Trivedi H.L., Vanikar A.V., Modi P.R., et al. In pursuit of the ultimate: the initial Ahmedabad journey toward transplantation tolerance. Transplant Proc 39 (2007) 653
30. Trivedi H.L., Mishra V.V., Vanikar A.V., et al. Embryonic stem cell derived and adult hematopoietic stem cell transplantation for tolerance induction in a renal allograft recipient-a case report. Transpl Proc 38 (2006) 3103
31. Ballet C., Roussey-Kesler G., Aubin J.T., et al. Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft. Am J Transplant 6 (2006) 2796
32. Louis S., Braudeau C., Giral M., et al. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 81 (2006) 398
33. Baeten D., Louis S., Braud C., et al. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients. J Am Soc Nephrol 17 (2006) 294
34. Brouard S., Dupont A., Giral M., et al. Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am J Transplant 5 (2005) 330
35. Roussey-Kesler G., Giral M., Moreau A., et al. Clinical operational tolerance after kidney transplantation. Am J Transplant 6 (2006) 736
36. Brouard S., Mansfield E., Braud C., et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A 104 (2007) 15448
37. Fischer T., Schobel H., and Barenbrock M. Specific immune tolerance during pregnancy after renal transplantation. Eur J Obst Gynec Repr Biol 70 (1996) 217
38. Svendsen U.G., Aggestrup S., Heilmann C., et al. Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow. Eur Respir J 8 (1995) 334
39. Halloran P.F., Bromberg J., Kaplan B., et al. Tolerance versus immunosuppression: a perspective. Am J Transplant 8 (2008) 1365
40. Calne R. Prope tolerance-the future of organ transplantation from the laboratory to the clinic. Int Immunopharmacol 5 (2005) 163
41. Hematti P. Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) 22 (2008) 262